Biotinidase Deficiency
Biotinidase
Multiple Carboxylase Deficiency
Amidohydrolases
Biotin
Dermatitis, Seborrheic
Encyclopedias as Topic
Newborn screening for biotinidase deficiency in Brazil: biochemical and molecular characterizations. (1/10)
Biotinidase deficiency is an inherited metabolic disorder characterized by neurological and cutaneous symptoms. Fortunately, it can be treated and the symptoms prevented by oral administration of the vitamin biotin. Using dried blood-soaked filter paper cards, biotinidase activity was determined in the sera of 225,136 newborns in Brazil. Mutation analysis performed on DNA from 21 babies with low serum biotinidase activity confirmed that 3 had profound biotinidase deficiency (less than 10% of mean normal sera biotinidase activity), 10 had partial biotinidase deficiency (10 to 30% of mean normal serum activity), 1 was homozygous for partial biotinidase deficiency, 4 were heterozygous for either profound or partial deficiency, and 3 were normal. Variability in serum enzyme activities and discrepancies with mutation analyses were probably due to inappropriate handling and storage of samples sent to the laboratory. Obtaining an appropriate control serum at the same time as that of the suspected child will undoubtedly decrease the false-positive rate (0.09%). Mutation analysis can be used to confirm the genotype of these children. The estimated incidence of biotinidase deficiency in Brazil is about 1 in 9,000, higher than in most other countries. Screening and treatment of biotinidase deficiency are effective and warranted. These results strongly suggest that biotinidase deficiency should be included in the newborn mass screening program of Brazil. (+info)Impaired biotinidase activity disrupts holocarboxylase synthetase expression in late onset multiple carboxylase deficiency. (2/10)
(+info)Biotinidase deficiency with hypertonia as unusual feature. (3/10)
We report 3 cases of biotinidase deficiency presenting in early infancy with neurological and cutaneous manifestations. All of them had hypertonia (spasticity). Response to oral biotin was excellent. One of the cases showed 7D3I biotidase deficient mutation. (+info)Development and characterization of a mouse with profound biotinidase deficiency: a biotin-responsive neurocutaneous disorder. (4/10)
(+info)Peculiar neuroimaging and electrophysiological findings in a patient with biotinidase deficiency. (5/10)
(+info)Evaluation of the probabilistic distribution of dietary biotin intake in Japan using Monte Carlo simulation. (6/10)
Biotin is a widely distributed water soluble vitamin. Adequate intake of biotin was set at 50 microg/d in Japan 2010. Recently, the importance of the application of probabilistic techniques to estimate the share of the population at risk of deficient and excessive nutrient intake has been increasingly emphasized for assessing nutrient adequacy. Monte Carlo simulation, a computer-based method of analysis that uses statistical sampling techniques yielding a probabilistic approximation to the solution of a mathematical model, has been used to estimate the probabilistic distribution of the dietary intake of food chemicals. For this study, we used two preliminary models to estimate the dietary biotin intake with food consumption data based on the National Health and Nutrition Survey in Japan. One is evaluated by biotin concentration data from the total diet study; the other is a dataset of biotin concentration in individual foods. After removing outliers from the individual foods dataset, probability density distributions from two models showed analogous mean, median, 5th percentile, and 95th percentile values. The daily biotin intakes from these probabilistic methods showed that more than 80% of the Japanese population had higher than the adequate intake of biotin. However, the contribution of each food group to the total daily biotin intake was somewhat different. Improvement of these methods necessitates the collection of more actual data associated with sample compositional variability and evaluation of uncertainty associated with the food group classification of biotin. (+info)Measurement of 3-hydroxyisovaleric acid in urine from marginally biotin-deficient humans by UPLC-MS/MS. (7/10)
(+info)Neurological deficits in mice with profound biotinidase deficiency are associated with demylination and axonal degeneration. (8/10)
(+info)Biotinidase deficiency is a genetic disorder that affects the body's ability to recycle and reuse biotin, a type of B vitamin. Biotinidase is an enzyme that helps release biotin from proteins in the food we eat and recycle it for use by the body.
In people with biotinidase deficiency, the biotinidase enzyme is either partially or completely missing, leading to a decrease in available biotin. This can result in a variety of symptoms, including seizures, developmental delays, hearing and vision loss, skin rashes, hair loss, and muscle weakness.
There are two main types of biotinidase deficiency: partial deficiency and profound deficiency. Partial deficiency means that some biotinidase activity is present, but not enough to prevent symptoms. Profound deficiency means that there is little or no biotinidase activity, resulting in more severe symptoms.
Biotinidase deficiency can be diagnosed through a blood test that measures the level of biotinidase enzyme activity. Treatment typically involves taking biotin supplements to replace the missing biotin and prevent symptoms from developing or worsening. With early diagnosis and treatment, people with biotinidase deficiency can often lead normal lives.
Biotinidase is an enzyme that is responsible for the release of biotin, a vital nutrient, from proteins in the body. Biotin is essential for various metabolic processes, including the synthesis of fatty acids and glucose. Biotinidase deficiency can lead to serious health problems, such as seizures, developmental delays, and hearing and vision loss. Therefore, biotinidase levels are often measured in newborn screening tests to identify babies who may be at risk for this rare but treatable condition.
Multiple carboxylase deficiency (MCD) is a rare genetic disorder that affects the body's ability to metabolize certain amino acids, particularly those that contain sulfur. It is caused by mutations in the genes responsible for producing enzymes involved in the biotin-dependent carboxylation reactions, which are critical for various metabolic processes in the body.
There are two major types of MCD:
1. Profound multiple carboxylase deficiency (also known as Type II biotinidase deficiency): This form is more severe and is caused by a defect in the holocarboxylase synthetase enzyme, which is responsible for attaching biotin to several carboxylases.
2. Biotin-responsive multiple carboxylase deficiency (also known as Type I biotinidase deficiency): This form is milder and is caused by a defect in the biotinidase enzyme, which recycles biotin in the body. However, it can be treated with biotin supplementation.
Symptoms of MCD may include:
* Developmental delay
* Seizures
* Hypotonia (low muscle tone)
* Ataxia (lack of coordination)
* Rash
* Hair loss
* Acidosis (high levels of acid in the body)
* Coma and even death, if left untreated
Early diagnosis and treatment with biotin supplementation can significantly improve outcomes for individuals with MCD.
Amidohydrolases are a class of enzymes that catalyze the hydrolysis of amides and related compounds, resulting in the formation of an acid and an alcohol. This reaction is also known as amide hydrolysis or amide bond cleavage. Amidohydrolases play important roles in various biological processes, including the metabolism of xenobiotics (foreign substances) and endogenous compounds (those naturally produced within an organism).
The term "amidohydrolase" is a broad one that encompasses several specific types of enzymes, such as proteases, esterases, lipases, and nitrilases. These enzymes have different substrate specificities and catalytic mechanisms but share the common ability to hydrolyze amide bonds.
Proteases, for example, are a major group of amidohydrolases that specifically cleave peptide bonds in proteins. They are involved in various physiological processes, such as protein degradation, digestion, and regulation of biological pathways. Esterases and lipases hydrolyze ester bonds in various substrates, including lipids and other organic compounds. Nitrilases convert nitriles into carboxylic acids and ammonia by cleaving the nitrile bond (C≡N) through hydrolysis.
Amidohydrolases are found in various organisms, from bacteria to humans, and have diverse applications in industry, agriculture, and medicine. For instance, they can be used for the production of pharmaceuticals, biofuels, detergents, and other chemicals. Additionally, inhibitors of amidohydrolases can serve as therapeutic agents for treating various diseases, such as cancer, viral infections, and neurodegenerative disorders.
Biotin is a water-soluble vitamin, also known as Vitamin B7 or Vitamin H. It is a cofactor for several enzymes involved in metabolism, particularly in the synthesis and breakdown of fatty acids, amino acids, and carbohydrates. Biotin plays a crucial role in maintaining healthy skin, hair, nails, nerves, and liver function. It is found in various foods such as nuts, seeds, whole grains, milk, and vegetables. Biotin deficiency is rare but can occur in people with malnutrition, alcoholism, pregnancy, or certain genetic disorders.
Seborrheic dermatitis is a common, inflammatory skin condition that mainly affects the scalp, face, and upper part of the body. It causes skin irritation, flaking, and redness, often in areas where the skin is oily or greasy. The exact cause of seborrheic dermatitis is not fully understood, but it appears to be related to a combination of genetic, environmental, and microbial factors.
The symptoms of seborrheic dermatitis can vary in severity and may include:
* Greasy or flaky scales on the scalp, eyebrows, eyelashes, ears, or beard
* Redness and inflammation of the skin
* Itching, burning, or stinging sensations
* Yellow or white crusty patches on the scalp or other affected areas
* Hair loss (in severe cases)
Seborrheic dermatitis is a chronic condition that tends to flare up and then subside over time. While there is no cure for seborrheic dermatitis, various treatments can help manage the symptoms and prevent complications. These may include medicated shampoos, topical creams or ointments, and lifestyle changes such as stress reduction and avoiding triggers that worsen symptoms.
It is important to note that seborrheic dermatitis should not be confused with other skin conditions, such as psoriasis or eczema, which may have similar symptoms. A healthcare professional can provide a proper diagnosis and recommend appropriate treatment options based on the individual's specific needs.
An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.
Neurocutaneous syndromes are a group of rare, genetic disorders that primarily affect the nervous system and skin. These conditions are present at birth or develop in early childhood. They are characterized by the growth of benign tumors along nerve pathways (neurocutaneous) and various abnormalities of the skin, eyes, brain, spine, and other organs.
Some common examples of neurocutaneous syndromes include:
1. Neurofibromatosis type 1 (NF1): A condition characterized by multiple café-au-lait spots on the skin, freckling in the axillary and inguinal regions, and neurofibromas (benign tumors of the nerves).
2. Neurofibromatosis type 2 (NF2): A condition that primarily affects the auditory nerves and is characterized by bilateral acoustic neuromas (vestibular schwannomas), which can cause hearing loss, tinnitus, and balance problems.
3. Tuberous sclerosis complex (TSC): A condition characterized by benign tumors in various organs, including the brain, skin, heart, kidneys, and lungs. The skin manifestations include hypomelanotic macules, facial angiofibromas, and shagreen patches.
4. Sturge-Weber syndrome (SWS): A condition characterized by a port-wine birthmark on the face, which involves the trigeminal nerve distribution, and abnormal blood vessels in the brain, leading to seizures, developmental delays, and visual impairment.
5. Von Hippel-Lindau disease (VHL): A condition characterized by the growth of benign tumors in various organs, including the brain, spinal cord, kidneys, pancreas, and adrenal glands. The tumors can become malignant over time.
6. Ataxia-telangiectasia (A-T): A condition characterized by progressive ataxia (loss of coordination), oculocutaneous telangiectasias (dilated blood vessels in the skin and eyes), immune deficiency, and increased risk of cancer.
Early diagnosis and management of neurocutaneous disorders are essential to prevent complications and improve outcomes. Regular follow-up with a multidisciplinary team, including neurologists, dermatologists, ophthalmologists, geneticists, and other specialists, is necessary to monitor disease progression and provide appropriate interventions.
Biotinidase deficiency
Delayed milestone
List of OMIM disorder codes
Multiple carboxylase deficiency
Biotin deficiency
Dog coat
Biotinidase
Newborn screening
Newborn Screening Saves Lives Reauthorization Act of 2013
Holocarboxylase synthetase deficiency
Biotin
Biocytin
3-Methylcrotonyl-CoA carboxylase deficiency
Andrea Superti-Furga
Lactic acidosis
Chromosome 3
Medical genetics
Congenital disorders of amino acid metabolism
List of diseases (B)
Hair loss
Causes of autism
List of ICD-9 codes 240-279: endocrine, nutritional and metabolic diseases, and immunity disorders
List of MeSH codes (C18)
List of MeSH codes (C16)
List of disorders included in newborn screening programs
Propionic acidemia
Biotinidase deficiency - Wikipedia
Biotinidase deficiency: MedlinePlus Genetics
Biotinidase Deficiency: Background, Pathophysiology, Epidemiology
Clinical aspects of hereditary hearing loss | Genetics in Medicine
Biotin Deficiency: Side Effects, Causes, and More
Adult Biotinidase Deficiency and you - GOT BADDOG
Biotinidase deficiency (Concept Id: C0220754) - MedGen - NCBI
pediatric neurology: High CSF lactate in biotinidase deficiency
Biotinidase deficiency: Same-day TAT at The Medical Dictionary
Biotinidase deficiency is a rare, potentially treatable cause of peripheral neuropathy with or without optic neuropathy in...
Good Laboratory Practices for Biochemical Genetic Testing and Newborn Screening for Inherited Metabolic Disorders
Holocarboxylase Synthetase Deficiency Clinical Presentation: History, Physical, Causes
Metabolic Crises | SpringerLink
Article - Billing and Coding: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs) ...
Information of NSP Disorders - Delaware Health and Social Services - State of Delaware
Resources for Newborn Screening in New Hampshire - Save Babies
About the test | National Screening Unit
Newborn Screening for IEMs
Expanded Carrier Screening | Thermo Fisher Scientific - US
Pediatric Genetic Care | MaineHealth
Treatment of congenital lactic acidosis with dichloroacetate | Archives of Disease in Childhood
Newborn Screening Program Disorders | South Dakota Department of Health
9 biotin-rich foods to add to your diet
Let's not get too excited about genome sequencing of healthy newborns. Here's why! | Blogs | CDC
Can You Guess June's Mystery Condition? - American Academy of Ophthalmology
urofacial syndrome - Ontology Browser - Rat Genome Database
Genetics of von Gierke Disease (Glycogen-Storage Disease Type 1): Background, Pathophysiology, Epidemiology
When Endocrine Test Results Don't Make Sense | myADLM.org
CYTAG® CGH Labeling kit - ENZ-42671 - Enzo Life Sciences
Presenting as rev1
- Complete biotinidase deficiency presenting as reversible progressive ataxia and sensorineural deafness. (medscape.com)
Profound15
- The more severe form of the disorder is called 'profound Biotinidase deficiency' and may cause delayed development, seizures, weak muscle tone (hypotonia), breathing problems, hearing and vision loss, problems with movement and balance (ataxia), skin rashes, hair loss (alopecia), and a fungal infection called candidiasis. (nih.gov)
- Furthermore, in rare cases, even individuals with profound deficiencies of biotinidase can be asymptomatic. (wikipedia.org)
- Profound biotinidase deficiency refers to situations where enzyme activity is 10% or less. (wikipedia.org)
- Profound biotinidase deficiency results when the activity of biotinidase is reduced to less than 10 percent of normal. (medlineplus.gov)
- Serum and cerebrospinal fluid studies remained unremarkable, but profound biotinidase enzyme activity deficiency was identified, as were three mutations in the BTD gene. (medscape.com)
- Chedrawi AK, Ali A, Al Hassnan ZN, Faiyaz-Ul-Haque M, Wolf B. Profound biotinidase deficiency in a child with predominantly spinal cord disease. (medscape.com)
- Increased incidence of profound biotinidase deficiency among Hispanic newborns in California. (medscape.com)
- Wolf B, Spencer R, Gleason T. Hearing loss is a common feature of symptomatic children with profound biotinidase deficiency. (medscape.com)
- Evaluation by a clinical geneticist or metabolic specialist annually for those with profound biotinidase deficiency and every two years for those with partial biotinidase deficiency. (nih.gov)
- Deficiency can be partial or profound. (medicalhomeportal.org)
- Newborn screening data in the United States indicate that the incidence of biotinidase deficiency is about 1:67,766 for profound deficiency and 1:24,957 for partial deficiency. (medicalhomeportal.org)
- Many mutations are known to cause profound deficiency, but a single mutation (p.D444H) is responsible for almost all cases of partial deficiency. (medicalhomeportal.org)
- Though usually diagnosed by newborn screening, partial or profound biotinidase deficiency should be considered in any child presenting with consistent clinical and biochemical findings. (medicalhomeportal.org)
- Successful outcomes of older adolescents and adults with profound biotinidase deficiency identified by newborn screening. (bvsalud.org)
- Older children and adolescents with profound biotinidase deficiency often exhibit motor limb weakness, spastic paresis, and decreased visual acuity. (beds.ac.uk)
Autosomal7
- Biotinidase deficiency is caused by genetic changes in the BTD gene and is inherited in an autosomal recessive manner. (nih.gov)
- Biotinidase deficiency is an autosomal recessive metabolic disorder in which biotin is not released from proteins in the diet during digestion or from normal protein turnover in the cell. (wikipedia.org)
- Biotinidase deficiency is inherited in an autosomal recessive pattern, which means the defective gene is located on an autosome, and two copies of the defective gene - one from each parent - must be inherited for a person to be affected by the disorder. (wikipedia.org)
- Biotinidase deficiency is an autosomal recessive condition. (medicalhomeportal.org)
- Biotinidase deficiency is caused by mutations in the BTD gene and inheritance is autosomal recessive. (medicalhomeportal.org)
- Biotinidase deficiency is an autosomal recessive genetic disorder which is not uncommon in the Saudi population. (who.int)
- A second healthy infant had two biotinidase deficiency ( BTD) variants, and as a result of participation in the BabySeq Project was diagnosed and treated for partial biotinidase deficiency, an autosomal recessive disorder. (cdc.gov)
Enzyme activity4
- Functionally, there is no significant difference between dietary biotin deficiency and genetic loss of biotin-related enzyme activity. (wikipedia.org)
- This biochemical analysis of biotinidase enzyme activity can be used as a 1st tier test for patients with a clinical suspicion of Biotinidase Deficiency. (ggc.org)
- [ 1 ] Two of the patients had almost total deficiency of hepatic glucose-6-phosphatase, whereas the remaining 4 had normal enzyme activity. (medscape.com)
- Follow-up testing will include quantitative plasma acylcarnitine profile, serum biotinidase, urine organic acids, and enzyme activity assay in white blood cells. (medicalhomeportal.org)
Seizures8
- Biotin deficiency can result in behavioral disorders, lack of coordination, learning disabilities and seizures. (wikipedia.org)
- Pediatric neurologists are trained to think of biotinidase deficiency to be associated with seizures in infancy, normally picked up in the first few months of life," he said. (medscape.com)
- Salbert BA, Pellock JM, Wolf B. Characterization of seizures associated with biotinidase deficiency. (medscape.com)
- Symptoms including seizures, developmental delay, cutaneous manifestations (skin rash, alopecia), optic atrophy, hearing loss, and respiratory problems occur only in those individuals with biotinidase deficiency prior to biotin treatment. (nih.gov)
- 10% mean normal serum biotinidase activity) usually appear between ages one week and ten years, typically with optic atrophy, hypotonia, seizures, hair loss, and skin rash. (nih.gov)
- Newborns are especially sensitive to biotinidase deficiency, and can have irreversible vision and hearing loss and seizures, although symptoms of biotinidase deficiency may also first occur in older children. (medicalhomeportal.org)
- Secondary deficiency is clinically similar, with failure to thrive, seizures, and other organic aciduria. (merckmanuals.com)
- Specifically how some other symptoms - " seizures, weak muscle tone (hypotonia), breathing problems, hearing and vision loss, problems with movement and balance (ataxia), skin rashes, hair loss (alopecia), and a fungal infection called candidiasis " - associated with biotinidase deficiency are not a million miles away from what has been talked about in some autism literature too (see also the comments section of another post here ). (blogspot.com)
Partial14
- The milder form is called 'partial Biotinidase deficiency' In some cases, these symptoms only appear during illness, infection, or other times of stress on the body. (nih.gov)
- Partial biotinidase deficiency is a milder form of this condition. (medlineplus.gov)
- Partial biotinidase deficiency occurs when biotinidase activity is reduced to between 10 percent and 30 percent of normal. (medlineplus.gov)
- High incidence of partial biotinidase deficiency cases in newborns of Greek origin. (medscape.com)
- Individuals with partial biotinidase deficiency (10%-30% of mean normal serum biotinidase activity) may develop symptoms only when stressed, such as during infection. (nih.gov)
- [ Wolf: 2010 ] In partial biotinidase deficiency, symptoms are usually triggered when the requirement for biotin increases (stress, infections, or fever). (medicalhomeportal.org)
- Elsewhere the investigators noted that the diagnostic test conducted following an elevated NBS result indicated that the infant did not have partial biotinidase deficiency. (cdc.gov)
- The investigators conducted a second diagnostic test using serum which, unlike the first test, indicated partial biotinidase deficiency. (cdc.gov)
- Even if that child does have partial biotinidase deficiency, it is unclear whether the child would experience adverse effects without treatment. (cdc.gov)
- One infant has been diagnosed and treated for partial biotinidase deficiency, with unknown clinical benefit. (cdc.gov)
- Individuals with partial biotinidase deficiency may have hypotonia, skin rash, and hair loss, particularly during times of stress. (beds.ac.uk)
- Ornithine transcarbamylase (OTC) deficiency can occur as a severe neonatal-onset disease in males (but rarely in females) and as a post-neonatal-onset (also known as "late-onset" or partial deficiency) disease in males and females. (beds.ac.uk)
- Males and heterozygous females with post-neonatal-onset (partial) OTC deficiency can present from infancy to later childhood, adolescence, or adulthood. (beds.ac.uk)
- A case of partial biotinidase deficiency associated with autism. (blogspot.com)
Galactosemia2
- This system is a robust, cost-efficient screening solution for seven Newborn screening disorders including congenital hypothyroidism, phenylketonuria, congenital adrenal hyperplasia, galactosemia, cystic fibrosis, biotinidase and G6PD deficiency. (usworldtoday.com)
- Galactosemia, biotinidase deficiency, cystic fibrosis, severe combined immunodeficiency or SCID, Pompe disease or glycogen storage disease type 2, mucopolysaccharidosis type 1, X-linked adrenoleukodystrophy, spinal muscular atrophy or SMA, critical congenital heart disease, and hearing loss are some of them. (byforbes.com)
Symptoms of biotinidase deficiency4
- When Do Symptoms of Biotinidase deficiency Begin? (nih.gov)
- citation needed] The symptoms of biotinidase deficiency (and dietary deficiency of biotin) can be quite severe. (wikipedia.org)
- Symptoms of biotinidase deficiency in neonates may make it difficult to differentiate holocarboxylase synthetase deficiency from biotinidase deficiency (see Pathophysiology), as patients with holocarboxylase synthetase deficiency also respond clinically well to biotin treatment. (medscape.com)
- What are the symptoms of biotinidase deficiency? (medicalhomeportal.org)
Patients with biotinidase deficiency2
- in several of the case reports of patients with biotinidase deficiency who presented with symptoms similar to NMO, the patients had been receiving immunomodulatory therapy. (medscape.com)
- The clinical history and the neuroradiological findings have been reviewed for 5 patients with biotinidase deficiency. (nih.gov)
Children with biotinidase deficiency2
- Most children with biotinidase deficiency are diagnosed by newborn screening tests. (medicalhomeportal.org)
- Although most children with biotinidase deficiency who take supplements will have no clinical or developmental problems, they may need more supplementation when physically stressed or going through puberty. (medicalhomeportal.org)
Newborn6
- Real time PCR assays to detect common mutations in the biotinidase gene and application of mutational analysis to newborn screening for biotinidase deficiency. (medlineplus.gov)
- Available at http://www.medicalhomeportal.org/newborn/biotinidase-deficiency . (medscape.com)
- Individuals with biotinidase deficiency who are diagnosed before they have developed symptoms (e.g., by newborn screening) and who are treated with biotin have normal development. (nih.gov)
- To confirm the diagnosis of 3MCC deficiency, work with Newborn Screening Services ( see NM providers [3] ) . (medicalhomeportal.org)
- Unfortunately, newborn screening is overlooked, which denies the opportunity for the metabolic disorder/deficiency to be corrected and for the baby to lead a normal life and transform into a healthy child and adult. (usworldtoday.com)
- Metabolic difficulties in newborn screening include phenylketonuria or PKU, methylmalonic acidemia, tyrosinemia, citrullinemia, and medium-chain acyl CoA dehydrogenase deficiency. (byforbes.com)
Newborns1
- 15. Immunophenotypic analysis of lymphocyte subsets in newborns with biotinidase deficiency. (nih.gov)
Acyl-CoA dehydroge1
- Anderson DR, Viau K, Botto LD, Pasquali M, Longo N . Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency. (aruplab.com)
Disorders6
- Four main factors contribute to vitamin B deficiency: an unbalanced diet, excessive alcohol intake, different drugs, and disorders that induce gut malabsorption. (researchgate.net)
- Elevations in plasma homocysteine levels may be associated with homocystinuria, cobalamin disorders, and vitamin B12 or folic acid deficiencies. (ggc.org)
- ABSTRACT The national neonatal screening programme in the United Arab Emirates currently includes 16 disorders: congenital hypothyroidism, sickle-cell diseases, congenital adrenal hyperplasia, biotinidase deficiency and 12 amino acid, organic acid and fatty acid disorders. (who.int)
- The incidence of screened disorders were 1:1 873 for congenital hypothyroidism, 1:14 544 for phenylketonuria, 1:3 526 for amino acid, organic acid and fatty acid disorders, 1:9 030 for classical congenital adrenal hyperplasia, 1:8 300 for biotinidase deficiency, 1:2 384 for sickle-cell disease and 1:121 for sickle-cell traits. (who.int)
- Symptoms of biotin deficiency are thinning and loss of body hair, scaly skin rashes around the eyes, nose, and mouth, brittle nails, and nervous system disorders. (bioanalyt.com)
- These technologies enable screening/monitoring for hearing loss, metabolic disorders/deficiencies, and neonatal jaundice as well as providing appropriate treatment solutions. (usworldtoday.com)
Congenital adrenal hyp1
- The conditions for which neonatal screening has been proposed in the Indian scenario include hearing loss, congenital hypothyroidism, congenital adrenal hyperplasia (CAH), and glucose-6-phosphate dehydrogenase (G6PD) deficiency besides biotinidase deficiency and phenylketonuria. (usworldtoday.com)
Activity of biotinidase2
- Mutations in the BTD gene reduce or eliminate the activity of biotinidase. (medlineplus.gov)
- Both the amount of biotin and the activity of biotinidase can be measured in the blood. (medicalhomeportal.org)
Diagnosis4
- Correct diagnosis of biotinidase deficiency can prevent ocular and spinal disability when the disorder is identified early and treated aggressively, the authors conclude. (medscape.com)
- Biotinidase deficiency: initial clinical features and rapid diagnosis. (medscape.com)
- Technical standards and guidelines for the diagnosis of biotinidase deficiency. (medicalhomeportal.org)
- Diagnosis of pyruvate dehydrogenase deficiency is confirmed by enzyme analysis of skin fibroblasts, DNA testing, or both. (merckmanuals.com)
Metabolic4
- Biotinidase deficiency (BIO): hereditary metabolic disorder in which too little biotin (vitamin H) is produced. (pns.nl)
- HMG-CoA-lyase deficiency (HMG): hereditary metabolic disorder in which the amino acid leucine is not broken down properly, resulting in suboptimal fatty acid oxidation leading to an energy deficiency. (pns.nl)
- 3-Methylcrotonyl-CoA carboxylase deficiency (3MCC deficiency): hereditary metabolic disorder in which certain proteins containing the amino acid leucine are not broken down sufficiently. (pns.nl)
- In 3MCC deficiency, a lack of 3-methylcrotonyl-CoA carboxylase (usually present in the liver, fibroblasts, and leukocytes) impairs the breakdown of leucine, resulting in metabolic acidosis and occasional hypoglycemia. (medicalhomeportal.org)
Incidence2
- Primary deficiency incidence is 1/250,000 births but may be higher in certain American Indian populations. (merckmanuals.com)
- The incidence of 3MCC deficiency is approximately 1:50,000. (medicalhomeportal.org)
Primary Carnitine1
- SLC22A5 sequencing is a molecular test used to identify variants in the gene associated with Primary Carnitine Deficiency, systemic. (ggc.org)
Multiple Carboxylase4
- Because several of these enzymes are impaired in biotinidase deficiency, the condition is considered a form of multiple carboxylase deficiency. (medlineplus.gov)
- Multiple carboxylase deficiency: clinical and biochemical improvement following neonatal biotin treatment. (medscape.com)
- Biotin supplementation is used for preventing and managing biotin deficiency associated with pregnancy, long-term parenteral nutrition, malnutrition, and multiple carboxylase deficiency. (jarrow.com)
- The late onset form of MULTIPLE CARBOXYLASE DEFICIENCY (deficiency of the activities of biotin-dependent enzymes propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase, and PYRUVATE CARBOXYLASE) due to a defect or deficiency in biotinidase which is essential for recycling BIOTIN. (bvsalud.org)
Enzymes4
- Another function of the biotinidase enzyme is to recycle biotin from enzymes that are important in metabolism (processing of substances in cells). (wikipedia.org)
- citation needed] Individuals lacking functional biotinidase enzymes can still have normal carboxylase activity if they ingest adequate amounts of biotin. (wikipedia.org)
- Biotinidase detaches biotin from lysine and generates free biotin that can be attached to many enzymes, called carboxylases, and possibly used in other chemical reactions. (medicalhomeportal.org)
- Biotinidase is responsible for biotin recycling and biotin is an essential cofactor for activation of the carboxylase enzymes. (who.int)
Severity of the enzyme1
- In children who aren't treated, prognosis will depend on the severity of the enzyme deficiency, with children with less than 10% of normal biotin levels having the worst prognosis. (medicalhomeportal.org)
Inherited disorder in which the body1
- Biotinidase deficiency is an inherited disorder in which the body is unable to recycle the vitamin biotin. (nih.gov)
Disorder4
- Biotinidase deficiency is a genetic disorder caused by the lack of an enzyme that processes biotin, an important cofactor in the processing of fats, carbohydrates, and protein. (medicalhomeportal.org)
- Absence of biotinidase leads to infantile or early childhood encephalopathy, seizure disorder, dermatitis, alopecia, neural deafness and optic atrophy. (who.int)
- One such condition is biotinidase deficiency , a disorder in which the body can't recycle the vitamin biotin. (healthline.com)
- For all individuals with OTC deficiency, typical neuropsychological complications include developmental delay, learning disabilities, intellectual disability, attention-deficit/hyperactivity disorder, and executive function deficits. (beds.ac.uk)
Pyruvate carboxylas1
- There is no effective treatment for pyruvate carboxylase deficiency, but some patients with primary deficiency and all those with secondary deficiencies should be given biotin supplementation 5 to 20 mg orally once a day. (merckmanuals.com)
Asymptomatic1
- Males with severe neonatal-onset OTC deficiency are asymptomatic at birth but become symptomatic from hyperammonemia in the first week of life, most often on day two to three of life, and are usually catastrophically ill by the time they come to medical attention. (beds.ac.uk)
Dehydrogenase1
- There is no clearly effective treatment for pyruvate dehydrogenase deficiency, although a low-carbohydrate or ketogenic diet and dietary thiamin supplementation have been beneficial for some patients. (merckmanuals.com)
Systemic1
- Dr. Scott's Pearl of Laboratory Medicine explores Biotinidase deficiency, a systemic enzyme defect that results in a variety of clinical features. (myadlm.org)
Vitamin6
- Without biotinidase activity, the vitamin biotin cannot be separated from foods and therefore cannot be used by the body. (wikipedia.org)
- Biotinidase removes biotin that is bound to proteins in food, leaving the vitamin in its free (unbound) state. (medlineplus.gov)
- Biotin deficiency may be caused by insufficient dietary uptake of biotin, drug-vitamin interactions and, perhaps, by increased biotin catabolism during pregnancy and in smokers. (researchgate.net)
- If these B vitamin deficiencies are left untreated, they can eventually cause symptoms such as peripheral neuropathy, heart attacks, strokes etc. (researchgate.net)
- This paper provides an in-depth summary of the most popular types of vitamin B, emphasizing why the body needs them, the symptoms of a deficiency, and what diet or foods are rich in them. (researchgate.net)
- Biotin is a vitamin, whereas biotinidase is an enzyme that allows our body to extract biotin from foods. (medicalhomeportal.org)
Supplementation4
- Once biotinidase deficiency is diagnosed, it is easy to treat with biotin supplementation, which is a very benign therapy and in most cases can override the system," Santoro noted. (medscape.com)
- Treatment is biotin supplementation depending on the level of existing biotinidase activity. (medicalhomeportal.org)
- Discussing how, within the increasingly large range of conditions that manifest autism or autistic behaviour(s), there may be one or two 'types' of autism that manifest biotin deficiency, there is a pretty obvious course of intervention as and when deficiency is found: supplementation. (blogspot.com)
- The deficiency of biotin is prevented by adequate consumption of foods rich in biotin or biotin supplementation. (bioanalyt.com)
3MCC deficiency1
- See 3MCC Deficiency - Information for Parents (STAR-G) . (medicalhomeportal.org)
Mutations2
- Mutations in the BTD gene cause biotinidase deficiency. (wikipedia.org)
- There are at least 21 different mutations that have been found to lead to biotinidase deficiency. (wikipedia.org)
Neonatal1
- Wolf B. Worldwide survey of neonatal screening for biotinidase deficiency. (medscape.com)
Malabsorption1
- Biotin deficiency is most common in people with congenital biotinidase deficiency, malabsorption (such as short-gut syndrome), pregnancy, alcoholism, and in people receiving long-term parenteral nutrition. (jarrow.com)